UB Paderborn / Katalog / Suche / in CDI

1 – 11 von 11

Sortiert nach

Therapeutic Drug Monitoring of Asparaginase: Intra-individual Variability and Predictivity in Children With Acute Lymphoblastic Leukemia Treated With PEG-Asparaginase in the AIEOP-BFM Acute Lymphoblastic Leukemia 2009 Study

Therapeutic drug monitoring, 2020-06, Vol.42 (3), p.435

2020

Link zum Volltext

Verfügbarkeit prüfen

Population Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia: Treatment Phase Dependency and Predictivity in Case of Missing Data

European journal of drug metabolism and pharmacokinetics, 2021-03, Vol.46 (2), p.289-300

2021

Link zum Volltext

Verfügbarkeit prüfen

Incidence of Hypersensitivity Reactions (HSR) Reactions (HSR) to Peg-Asparaginase (PEG-ASP) in 6136 Patients Treated in the AIEOP-BFM ALL 2009 Study Protocol

Blood, 2019-11, Vol.134 (Supplement_1), p.2589-2589

2019

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of daunorubicin and daunorubicinol in infants with leukemia treated in the interfant 99 protocol

Pediatric blood & cancer, 2010-03, Vol.54 (3), p.355-360

2010

Link zum Volltext

Verfügbarkeit prüfen

[11]Anthrahelicene on InSb(001) c(8×2): A Low-Temperature Scanning Probe Microscopy Study

Chemphyschem, 2010-11, Vol.11 (16), p.3522-3528

2010

Link zum Volltext

Verfügbarkeit prüfen

10 Jahre Qualitätssicherung im Hautarztverfahren. Clearingstelle der ABD Teil II: 2003-2009

Journal der Deutschen Dermatologischen Gesellschaft, 2011-01, Vol.9 (1), p.42-46

2011

Link zum Volltext

Verfügbarkeit prüfen

PH-Triazaphosphorine

Zeitschrift für Naturforschung. B, A journal of chemical sciences, 1971-07, Vol.26 (7), p.650-655

1971

Link zum Volltext

Verfügbarkeit prüfen

1 – 11 von 11

Suche als RSS-Feed

Aktive Filter

SpracheDeutsch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(11)
Mit Volltextzugriff
(10)

Publikationsform

Artikel
(11)

Sprache

Englisch
(11)
Japanisch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Therapeutic Drug Monitoring of Asparaginase: Intra-individual Variability and Predictivity in Children With Acute Lymphoblastic Leukemia Treated With PEG-Asparaginase in the AIEOP-BFM Acute Lymphoblastic Leukemia 2009 Study

Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study

Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study

Population Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia: Treatment Phase Dependency and Predictivity in Case of Missing Data

Impact of Additional Intensive L-Asparaginase Therapy during Consolidation Phase for High-Risk Acute Lymphoblastic Leukemia: Results of a Randomized Controlled Trial in the AIEOP-BFM ALL 2009 Protocol

Incidence and Characteristics of Hypersensitivity Reactions to PEG‐asparaginase Observed in 6136 Children With Acute Lymphoblastic Leukemia Enrolled in the AIEOP‐BFM ALL 2009 Study Protocol

Incidence of Hypersensitivity Reactions (HSR) Reactions (HSR) to Peg-Asparaginase (PEG-ASP) in 6136 Patients Treated in the AIEOP-BFM ALL 2009 Study Protocol

Pharmacokinetics of daunorubicin and daunorubicinol in infants with leukemia treated in the interfant 99 protocol

[11]Anthrahelicene on InSb(001) c(8×2): A Low-Temperature Scanning Probe Microscopy Study

10 Jahre Qualitätssicherung im Hautarztverfahren. Clearingstelle der ABD Teil II: 2003-2009

PH-Triazaphosphorine

Aktive Filter

Suchergebnisse filtern